Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice. [electronic resource]
Producer: 20140706Description: 487-96 p. digitalISSN:- 1521-0103
- Acetyl-CoA C-Acyltransferase -- antagonists & inhibitors
- Angina Pectoris -- drug therapy
- Animals
- Cells, Cultured
- Diet, High-Fat
- Fatty Acids -- metabolism
- Glucose Tolerance Test
- Insulin -- blood
- Insulin Resistance
- Lipid Metabolism -- drug effects
- Mice
- Mice, Inbred C57BL
- Muscle Fibers, Skeletal -- drug effects
- Myocytes, Cardiac -- drug effects
- Obesity -- complications
- Oxidation-Reduction
- Rats
- Trimetazidine -- administration & dosage
- Vasodilator Agents -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.